Abstract
In vivo reversal of doxorubicin resistance by a new tiapamil analog Ro11-2933.
M A Alaoui-Jamali, R L Schecter, Y M Rustum, M G Centurioni, S Lehnert and G Batist
Journal of Pharmacology and Experimental Therapeutics March 1993, 264 (3) 1299-1304;